St Luke’s Symposium November 2010 St Luke’s Symposium November 2010 National Clinical Programmes Dr Barry White Director of Quality & Clinical Care HSE 1
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
National Clinical Programmes
Dr Barry WhiteDirector of Quality & Clinical Care
HSE
1
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
How does the Directorate link to other HSE Management
functions? The Directorate of Quality and clinical care is one of a number of integrated HSE management trams design to
deliver an efficient and effective patient centric Health Service
2
PLAN IMPROVE
Define the way clinical services should
be delivered, resourced & measured
Objective
Leadership responsibility
Co-ordinate the development ofService Plan
Management Plans
Mange the allocation of
resources
Identification of service
improvement solutions
Corporate Planning & Control Processes
Directorate(CPCP)
Quality & Clinical Care Directorate
(DQCC)
Integrated Services Division
(ISD)
Tactical – ISDStrategic – DQCC
Operational – Infrastructure
Monitor & report performance
against targets and plans
Monitor – ISDReport – CPCP
Key Management processes
Enabling management processes
Human Resource Management
Financial Management
Infrastructure & IT Management
Communications
DEFINE MANAGE MONITOR& REPORT
St Luke’s Symposium November 2010 3
Mission
Better care and better use of resources
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
3 key issues
• Clinical leadership for subject matter expertise and credibility (public and clinical)
• Standardised care (save lives and saves money)
• Programmatic approach
4
St Luke’s Symposium November 2010 5
What is the mission of the Directorate of Quality & Clinical
Care? Better care and better use of resources
• If patients get the right treatment we can save lives and money• 70% of healthcare spend is on 6 chronic diseases (with 80% of this on patients
with >3 chronic diseases)• 70% of deaths are associated with these chronic diseases• Chronic disease management is delivered in an unstructured manner and 50% of
patients do not receive the right treatment• If patients received the right treatment this would save 25%-40% of healthcare
spend• E.g. Stroke in Ireland • Sustainable healthcare improvements are clinically led (KP, Finland Asthma etc)• A structured and clinically led approach to chronic disease management will
improve outcomes and save money
St Luke’s Symposium November 2010 6
Why take a programmatic approach to change?
The advantages of developing chronic disease management programs are:
– Structured approach to disease management to ensure patients gets the right treatment
– Change is led by experienced clinicians with expertise in disease and service delivery.
– Generates clinical buy-in and ownership from the start. Also provides opportunity for bottom-up and top down change by engaging Colleges and professional bodies.
– Enables greater organisational responsiveness i.e. frontline staff can access the top of the organisation in one step via the national lead.
– Provides a sustained focus
– The appointment of Prof. Keane as the Director of the National Cancer Control Programme (NCCP), demonstrates the importance of having an expert in the relevant clinical area to engage with evidence to the public, media, politicians and other clinicians.
St Luke’s Symposium November 2010
St Luke’s Symposium November 2010 8
Overall principles
• Set goals that achieve gains in cost, quality, access and compliance• Set goals that are simple and meaningful – e.g. prevent 300 stroke
deaths • Target what is achievable • Target areas that can sustainable short term gains• Nationalise existing local good practice - do not reinvent the wheel • Ensure local ownership (authority, accountability and responsibility)• Ensure patient involvement• Embed data at the centre of all assessments and decisions• Detailed implementation and communication plans
St Luke’s Symposium November 2010 9
What are the stages of the standardised approach to managing
change?
Initiate program
Scope the program
Set Goals
Measure & analyse
performance
Validate solutions
Detailed solution design
Implement solutions
Sustain & improve
performance
1 2 3 4 5 6 7 8
1 2 3 4
Define key
issues & solutions
Checkpoints with the Program Advisory Group, the Director of Quality & Clinical Care and Steering group
St Luke’s Symposium November 2010St Luke’s Symposium November 2010 10
Programs & leads
Medication Management
- PM Mairead Gleeson 4. Acute Hospital Services
To be appointed
Paediatrics
Rehab
St Luke’s Symposium November 2010 11
Overall principles 1. Clinician led change supported by multidisciplinary teams
2. Patient involvement
3. Programmatic approach focused on implementation
4. Set quality, access & cost goals that are meaningful – e.g. prevent 300 stroke deaths
5. Nationalise existing local best practice
6. Ensure local ownership
How success will be assessed : 5% of marks for the solution 95% for successful implementation
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
Key Acute Medicine features of the Blue Print
• Acute Medical Units, Acute Medical Assessment Units and Medical Assessment Units
• New working practices/continuous presence
• National Early Warning Score
• Rapid access to out-patients
• Navigation hub/bed bureau and Case Manager
• Retrieval service
• Hospital models
• Metrics
• New approach to education, training and development
15
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
St Luke’s Symposium November 2010St Luke’s Symposium November 2010 17
Key Achievements of Programmes to date
1. Establish programme teams, governance structures and objectives2. Detailed solution design phase for Heart failure, COPD, epilepsy, Diabetes,
Asthma, Stroke and Acute Medicine 3. Guidelines, Bundles, Models of care complete for above4. Design complete and implementation commenced neurology and
dermatology OPD5. Agreement of Avlos / Day of Surgery & Day Surgery Rates – Roll out 20116. Productive theatre – 5 Sites commenced 7. Surgical and Critical Care Audit implementation planning underway8. Patient information website – 2011 9. Blue print for the future
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
Heart Failure
• Prevent 2000 heart failure exacerbations requiring admission per year
• Every appropriate patient admitted to hospital with heart failure has access to structured heart failure programme
• Save 200 beds per year• ROI 3:1 in 3 years• Investment involves redeployment of existing nursing staff
18
St Luke’s Symposium November 2010St Luke’s Symposium November 2010
Epilepsy
• Convert 8000 patients to being seizure free• Save one life per week • All patients have access to structured epilepsy programme• Save 60 beds• ROI 3:1 in 3 yrs• Investment requires redeployment of existing staff
19
St Luke’s Symposium November 2010St Luke’s Symposium November 2010 20
Summary
• Major change in clinical leadership and role of Colleges has been implemented
• Programmes rapidly progressing• Solutions identified • Excellent clinical engagement (doctors, nurses, and Therapists)• Wide stakeholder buy in (Colleges, Nursing, Therapists, HSE SMT, HSE
Board, DOHC, Patient groups, Unions) • Integration underway into single plan• Major financial cutbacks underway• Increasing need for radical change which needs to be clinician led• Enough talking – time for action